Item: Quant Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl
Rating: Unrated
Author: Morningstar

Home › Mutual Funds › Quant Mutual Fund › Quant Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl

14.044 (1.826%)

NAV on May 17, 2024

Category Equity:

Investment StyleBox

Mid Growth

Total Assets 279 cr

Turnover Ratio

Expense Ratio 0.68%

Exit Load 1.00%if redeemed within
15 Days0.00%if redeemed after 15 Days

Returns

1M: 2.38%
1Y: N/A
3M: 0.50%
3Y: N/A
6M: 26.27%
5Y: N/A

Min Investment 5,000

Buy Now Start SIP

ADDITIONAL INFO

Fund Manager Sanjeev Sharma (Since 10 months) Vasav Sahgal (Since 10 months) Ankit A. Pande (Since 10 months) Sandeep Tandon (Since 10 months)

ISIN INF966L01CF5

Fund Family Quant

P/E Ratio 30.56

P/B Ratio 3.37

Launch Date July 18, 2023

Benchmark S&P BSE Healthcare TR INR

SECTOR WEIGHTINGS (%)

Financial 8.67%

Industrial 0.0%

Technology 0.0%

Basic Materials 0.0%

Consumer Cyclical 0.0%

Utilities Services 0.0%

Healthcare Services 81.84%

Energy Services 9.48%

Communication Services 0.00%

Consumer Defensive 0.00%

Real Estate 0.00%

INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

Dividends that would otherwise be paid out to investors are instead used to purchase more units in the fund. Not as tax efficient as Growth.

View Factsheet

Top Rated
Top Performing

-

Best Arbitrage Fund Funds

NAME		LATEST NAV	RETURNS 1y	FUND ASSETS	Expense RATIO	RISK
Quant Healthcare Fund Direct Growth		14.042	—	279 cr	0.68%	-

Best Sector Healthcare Funds

NAME	LATEST NAV	RETURNS 1y	FUND ASSETS	Expense RATIO	RISK
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth	32.860	58.21%	3,835 cr	1.04%	-
Tata India Pharma & Healthcare Fund Direct Growth	29.094	55.80%	894 cr	0.84%	-
Nippon India Pharma Fund - Direct Plan - Growth Plan	478.689	54.89%	7,133 cr	0.92%	-
SBI Healthcare Opportunities Fund Direct Growth	393.498	53.69%	2,667 cr	0.95%	-